Johns Hopkins ABX Guide
Rifamycin
INDICATIONS
FDA
FDA
- Treatment of travelers’ diarrhea due to noninvasive strains of Escherichia coli.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: April 8, 2019
Citation
Dzintars, Kathryn. "Rifamycin." Johns Hopkins ABX Guide, The Johns Hopkins University, 2019. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540709/all/Rifamycin.
Dzintars K. Rifamycin. Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540709/all/Rifamycin. Accessed December 1, 2024.
Dzintars, K. (2019). Rifamycin. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540709/all/Rifamycin
Dzintars K. Rifamycin [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. [cited 2024 December 01]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540709/all/Rifamycin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rifamycin
ID - 540709
A1 - Dzintars,Kathryn,Pharm.D., BCPS
Y1 - 2019/04/08/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540709/all/Rifamycin
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
